EUVIMEDEUVIMED entdecken
Crossref

Detection of the selective androgen receptor modulator S‐23 and its metabolites in equine urine and plasma following oral administration

Charlotte Cutler iD, Marjaana Viljanto iD, Pamela Hincks, Jocelyn Habershon-Butcher, James Scarth, Peter van Eenoo

Drug Testing and Analysis · 2025

DOI: 10.1002/dta.3758 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Charlotte Cutler und 5 weiteren Autor:innen. Beteiligte Einrichtung: LGC Ltd, Fordham, Cambridgeshire, UK. Hauptthemen laut MEDLINE: Substance Abuse Detection. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben. Gefördert von: British Horseracing Authority.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

S‐23 is an arylpropionamide selective androgen receptor modulator that has been investigated in animal models for use as a male hormonal contraceptive but is not yet available therapeutically. S‐23 is available alongside other selective androgen receptor modulators (SARMs) to purchase online via uncontrolled sites, sold as supplement products. It has been detected in several human doping cases, highlighting the importance of identifying the best analytical targets for equine doping control. The purpose of this study was to investigate the detection of S‐23 and its phase I metabolites in equine urine and plasma following a multiple dose oral administration to two Thoroughbred racehorses. Liquid chromatography‐high resolution mass spectrometry was used for metabolite identification, and liquid chromatography–tandem mass spectrometry was used for full sample analysis and generation of urine and plasma profiles. S‐23 and seven phase I metabolites were observed in urine following enzyme hydrolysis and solvolysis. The most abundant analyte detected was the hydroxylated 4‐amino‐2‐(trifluoromethyl)benzonitrile metabolite, which also allowed the longest duration of detection in urine from both horses, for up to 360 h following administration. The data suggest that this metabolite was likely to be highly conjugated with both sulphate and glucuronide moieties. In plasma, S‐23 and two phase I metabolites were observed. S‐23 was the most abundant analyte detected for both horses, allowing detection for up to 143 h post‐administration. To the best of the authors' knowledge, this is the first report of S‐23 and metabolites in equine urine and plasma samples.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substance Abuse DetectionAnimalsHorsesAdministration, OralTandem Mass SpectrometryMaleDoping in SportsChromatography, LiquidReceptors, Androgen

Stichwörter der Autor:innen

SARMsarylpropionamidedoping controlhorsemetabolism

Substanzen

Receptors, Androgen

Autor:innen und Institutionen

  • LGC Ltd, Fordham, Cambridgeshire, UK.
  • Doping Control Laboratory (DoCoLab), Ghent University, Ghent, Belgium.
  • British Horseracing Authority, London, UK.

ORCID-Profile: Charlotte Cutler, Marjaana Viljanto

Förderung

  • British Horseracing Authority

Zitieren

APA

Cutler, C., Viljanto, M., Hincks, P., Habershon-Butcher, J., Scarth, J., & van Eenoo, P. (2025). Detection of the selective androgen receptor modulator S‐23 and its metabolites in equine urine and plasma following oral administration. Drug Testing and Analysis. https://doi.org/10.1002/dta.3758

Vancouver

Cutler C, Viljanto M, Hincks P, Habershon-Butcher J, Scarth J, van Eenoo P. Detection of the selective androgen receptor modulator S‐23 and its metabolites in equine urine and plasma following oral administration. Drug Testing and Analysis. 2025. doi:10.1002/dta.3758

BibTeX
@article{Cutler2025,
  author = {Cutler, Charlotte and Viljanto, Marjaana and Hincks, Pamela and Habershon-Butcher, Jocelyn and Scarth, James and van Eenoo, Peter},
  title = {Detection of the selective androgen receptor modulator S‐23 and its metabolites in equine urine and plasma following oral administration},
  journal = {Drug Testing and Analysis},
  year = {2025},
  doi = {10.1002/dta.3758}
}
Kostenlos starten →